Litcius/Paper detail

Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies

Laura Breda, Valentina Ghiaccio, Naoto Tanaka, Danuta Jarocha, Yasuhiro Ikawa, Osheiza Abdulmalik, Alisa Dong, Carla Casu, Tobias Raabe, Xiaochuan Shan, Gwenn Danet-Desnoyers, Aoife Doto, J.K. Everett, Frederic D. Bushman, Enrico Radaelli, Charles A. Assenmacher, James C. Tarrant, Natalie Hoepp, Ryo Kurita, Yukio Nakamura, Virginia Guzikowski, Kim Smith‐Whitley, Janet L. Kwiatkowski, Stefano Rivella

2021Molecular Therapy23 citationsDOIOpen Access PDF

Topics & Concepts

Genetic enhancementBiologyViral vectorGenome editingGenomeGeneGeneticsRecombinant DNAPrenatal Screening and DiagnosticsHemoglobinopathies and Related DisordersCRISPR and Genetic Engineering